KIORA PHARMACEUTICALS, INC. Proceeds from Common Stock Issued
KIORA PHARMACEUTICALS, INC. (KPRX) reported Proceeds from Common Stock Issued of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2024-11-08
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2024-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of common stock for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2022 was $5.38M, a 69.69% decline from fiscal 2021.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2021 was $17.75M, a 254.90% increase from fiscal 2020.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2020 was $5.00M, a 166.67% increase from fiscal 2019.
- KIORA PHARMACEUTICALS, INC. proceeds from issuance of common stock for fiscal 2019 was $1.88M, a 81.45% decline from fiscal 2018.
| Period end | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock 0 month | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 3 month as first filed | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 6 month as first filed | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | ||||||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | |||||||||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-10 | ||||||||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $343.35K derived: sum of 2 quarters · filed 2024-11-08 | $442.31K 10-Q · filed 2024-11-08 | $442.31K derived: sum of 4 quarters · filed 2024-11-08 | |||||||
| 2023-06-30 | $343.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $442.31K 10-Q · filed 2024-08-09 | $442.31K derived: sum of 3 quarters · filed 2024-08-09 | $5.82M derived: sum of 4 quarters · filed 2024-08-09 | |||||||
| 2023-03-31 | $98.96K 10-Q · filed 2024-05-10 | $98.96K derived: sum of 2 quarters · filed 2024-05-10 | $5.48M derived: sum of 3 quarters · filed 2024-05-10 | $5.48M derived: sum of 4 quarters · filed 2024-05-10 | |||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $5.38M derived: sum of 2 quarters · filed 2023-03-23 | $5.38M derived: sum of 3 quarters · filed 2023-03-23 | $5.38M 10-K · filed 2023-03-23 | |||||||
| 2022-09-30 | $5.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $5.38M derived: sum of 2 quarters · filed 2022-11-09 | $5.38M 10-Q · filed 2022-11-09 | $5.38M derived: sum of 4 quarters · filed 2023-05-09 | |||||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $0.00 derived: sum of 3 quarters · filed 2023-05-09 | $9.76M derived: sum of 4 quarters · filed 2023-05-09 | |||||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2023-05-09 | $9.76M derived: sum of 3 quarters · filed 2023-05-09 | $9.76M derived: sum of 4 quarters · filed 2023-05-09 | |||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $9.76M derived: sum of 2 quarters · filed 2023-03-23 | $9.76M derived: sum of 3 quarters · filed 2023-03-23 | $17.75M 10-K · filed 2023-03-23 | $18.75M 10-K · filed 2022-04-15 | ||||||
| 2021-09-30 | $9.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $9.76M derived: sum of 2 quarters · filed 2022-11-09 | $17.75M 10-Q · filed 2022-11-09 | $18.24M derived: sum of 4 quarters · filed 2022-11-09 | |||||||
| 2021-08-11 | $9.80M 10-K · filed 2023-03-23 | ||||||||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $7.99M 10-Q · filed 2022-08-12 | $8.49M derived: sum of 3 quarters · filed 2022-08-12 | $8.49M derived: sum of 4 quarters · filed 2022-08-12 | |||||||
| 2021-03-31 | $7.99M 10-Q · filed 2022-07-08 | $8.49M derived: sum of 2 quarters · filed 2022-07-08 | $8.49M derived: sum of 3 quarters · filed 2022-07-08 | $8.49M derived: sum of 4 quarters · filed 2022-07-08 | |||||||
| 2020-12-31 | $498.69K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-07 | $498.69K derived: sum of 2 quarters · filed 2022-07-07 | $498.69K derived: sum of 3 quarters · filed 2022-07-07 | $5.00M 10-K/A · filed 2022-07-07 | |||||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $4.50M 10-Q · filed 2021-11-15 | $5.00M 10-Q · filed 2020-11-09 | $6.38M derived: sum of 4 quarters · filed 2021-11-15 | ||||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $4.50M 10-Q · filed 2021-08-12 | $6.38M derived: sum of 3 quarters · filed 2021-08-12 | $6.38M derived: sum of 4 quarters · filed 2021-08-12 | |||||||
| 2020-03-31 | $4.50M 10-Q · filed 2021-05-12 | $6.38M derived: sum of 2 quarters · filed 2021-05-12 | $6.38M derived: sum of 3 quarters · filed 2021-05-12 | $6.38M derived: sum of 4 quarters · filed 2021-05-12 | |||||||
| 2020-01-03 | $4.50M 10-K/A · filed 2022-07-07 | ||||||||||
| 2019-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $1.88M derived: sum of 2 quarters · filed 2021-03-25 | $1.88M derived: sum of 3 quarters · filed 2021-03-25 | $1.88M 10-K · filed 2021-03-25 | $1.78M 10-K · filed 2020-03-04 | ||||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 4 quarters · filed 2020-11-09 | |||||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | $0.00 derived: sum of 3 quarters · filed 2020-08-06 | $0.00 derived: sum of 4 quarters · filed 2020-08-06 | |||||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-06 | $0.00 derived: sum of 2 quarters · filed 2020-05-06 | $0.00 derived: sum of 3 quarters · filed 2020-05-06 | $10.11M derived: sum of 4 quarters · filed 2020-05-06 | |||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $0.00 derived: sum of 2 quarters · filed 2020-03-04 | $10.11M derived: sum of 3 quarters · filed 2020-03-04 | $10.11M 10-K · filed 2020-03-04 | |||||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $10.11M derived: sum of 2 quarters · filed 2019-11-07 | $10.11M 10-Q · filed 2019-11-07 | $10.11M derived: sum of 4 quarters · filed 2019-11-07 | |||||||
| 2018-06-30 | $10.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $10.11M 10-Q · filed 2019-08-08 | $10.11M derived: sum of 3 quarters · filed 2019-08-08 | $10.11M derived: sum of 4 quarters · filed 2019-08-08 | |||||||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-11 | $0.00 derived: sum of 2 quarters · filed 2019-03-01 | $0.00 derived: sum of 3 quarters · filed 2019-03-01 | $8.79M derived: sum of 4 quarters · filed 2019-03-01 | |||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $0.00 derived: sum of 2 quarters · filed 2019-03-01 | $8.79M derived: sum of 3 quarters · filed 2019-03-01 | $10.59M 10-K · filed 2019-03-01 | $11.92M 10-K · filed 2018-03-02 | ||||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $8.79M derived: sum of 2 quarters · filed 2018-11-13 | $10.59M 10-Q · filed 2018-11-13 | $11.92M 10-Q · filed 2017-11-14 | $10.59M derived: sum of 4 quarters · filed 2019-08-08 | ||||||
| 2017-06-30 | $8.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $10.59M 10-Q · filed 2018-08-03 | $11.92M 10-Q · filed 2017-08-04 | $10.59M derived: sum of 3 quarters · filed 2019-08-08 | $10.59M derived: sum of 4 quarters · filed 2019-08-08 | ||||||
| 2017-06-14 | $8.80M 10-K · filed 2018-03-02 | ||||||||||
| 2017-03-31 | $1.80M 10-Q · filed 2019-08-08 | $1.92M 10-Q · filed 2017-05-05 | $1.80M derived: sum of 2 quarters · filed 2019-08-08 | $1.80M derived: sum of 3 quarters · filed 2019-08-08 | $5.57M derived: sum of 4 quarters · filed 2019-08-08 | ||||||
| 2017-02-21 | $1.80M 10-Q · filed 2018-05-11 | ||||||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | -$52.00 derived: sum of 2 quarters · filed 2018-03-02 | $3.77M derived: sum of 3 quarters · filed 2018-03-02 | $3.77M 10-K · filed 2018-03-02 | |||||||
| 2016-09-30 | -$52.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $3.77M derived: sum of 2 quarters · filed 2017-11-14 | $3.77M 10-Q · filed 2017-11-14 | $3.77M derived: sum of 4 quarters · filed 2017-11-14 | |||||||
| 2016-06-30 | $3.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $3.77M 10-Q · filed 2017-08-04 | $3.77M derived: sum of 3 quarters · filed 2017-08-04 | $17.87M derived: sum of 4 quarters · filed 2017-08-04 | |||||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-05 | $0.00 derived: sum of 2 quarters · filed 2017-05-05 | $14.10M derived: sum of 3 quarters · filed 2017-05-05 | ||||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $14.10M derived: sum of 2 quarters · filed 2017-02-23 | $14.10M 10-K · filed 2017-02-23 | ||||||||
| 2015-09-30 | $14.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $14.10M 10-Q · filed 2016-11-01 | |||||||||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |